Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4

Patients with triple-negative breast cancer (TNBC) have a poor prognosis, partly because of the absence of targeted therapies. Recognition of the key role of immune responses against cancer has allowed the advent of immunotherapy, focused on the inhibition of negative immune checkpoints, such as CTL...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarrete-Bernal, María G. C., Cervantes-Badillo, Mayte G., Martínez-Herrera, Jose Fabián, Lara-Torres, César O., Gerson-Cwilich, Raquel, Zentella-Dehesa, Alejandro, Ibarra-Sánchez, María de Jesús, Esparza-López, José, Montesinos, Juan J., Cortés-Morales, Víctor Adrián, Osorio-Pérez, Diego, Villegas-Osorno, Diana A., Reyes-Sánchez, Eduardo, Salazar-Sojo, Pablo, Tallabs-Utrilla, Luis F., Romero-Córdoba, Sandra, Rocha-Zavaleta, Leticia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419680/
https://www.ncbi.nlm.nih.gov/pubmed/32850353
http://dx.doi.org/10.3389/fonc.2020.01206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419680/
https://www.ncbi.nlm.nih.gov/pubmed/32850353
http://dx.doi.org/10.3389/fonc.2020.01206

Ejemplares similares